| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.167.3926.1749 |
| P698 | PubMed publication ID | 5461272 |
| P2093 | author name string | M Collins | |
| G Cohen | |||
| P433 | issue | 3926 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcoholism | Q15326 |
| P304 | page(s) | 1749-1751 | |
| P577 | publication date | 1970-03-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism | |
| P478 | volume | 167 |
| Q52575951 | 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. |
| Q40087144 | 2 The β-Adrenomimetic Activity of Tetrahydroisoquinolines and Tetrahydronaphthalenes |
| Q44888153 | 6,7-Dihydroxytetrahydroisoquinoline: Uptake and Storage by Peripheral Sympathetic Nerve of the Rat |
| Q67341024 | 6,7‐Dihydroxytetrahydroisoquinoline: evidence for in vivo inhibition of intraneuronal monoamine oxidase |
| Q62608329 | A contribution to the asymmetric synthesis of isoquinolines: Concise stereoselective approach to (3S,4S)-6,7-dimethoxy-4-hydroxy-3-phenyl-1,2,3,4-tetrahydroisoquinoline |
| Q44426235 | A re-evaluation of the role of tetrahydropapaveroline in ethanol consumption in rats |
| Q52701532 | A study on diazepam and postwithdrawal drinking of ethanol solution in rats |
| Q73289752 | A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas |
| Q39709918 | Acetaldehyde Metabolism In Vivo During Ethanol Oxidation |
| Q67045872 | Adrenergic nerve degeneration induced by condensation products of adrenaline and acetaldehyde |
| Q52270153 | Alcohol Addiction: Are the Endogenous Opioids Involved? |
| Q48298337 | Alcohol Drinking: Abnormal Intake Caused by Tetrahydropapaveroline in Brain |
| Q34018472 | Alcohol and Aldehyde Metabolism in Brain |
| Q67376933 | Alcohol and the nervous system |
| Q48269458 | Alcohol drinking in the rat induced by acute intracerebral infusion of two tetrahydroisoquinolines and a β-carboline |
| Q40308425 | Alcohol, liver injury and protein metabolism |
| Q39102105 | Alkaloid products in the metabolism of alcohol and biogenic amines |
| Q67281254 | Alkaloids' in mammalian tissues. I. Condensation of L-dopa and its two mono-O-methyl ethers with formaldehyde and acetaldehyde |
| Q34826218 | Alkaloids, alcohol and Parkinson's disease |
| Q67427463 | Alteration of Ethanol Preference in Rats; Effects of β-Carbolines |
| Q48663708 | Alterations in ethanol preference in the rat: the role of brain biogenic amines |
| Q67653857 | Analgesic effects of 3-carboxysalsolinol alone and in combination with morphine |
| Q71269600 | Analysis of salsolinol and salsoline in biological samples using deuterium-labelled internal standards and gas chromatography--mass spectrometry |
| Q67931623 | Analysis of salsolinol in human brain using high-performance liquid chromatography with electrochemical detection |
| Q73588554 | Analysis of tetrahydro-beta-carboline-3-carboxylic acids in foods by solid-phase extraction and reversed-phase high-performance liquid chromatography combined with fluorescence detection |
| Q33422069 | Analysis of the bioactive alkaloids tetrahydro-beta-carboline and beta-carboline in food |
| Q51416748 | Are there possibilities for the detection of chronically elevated alcohol consumption by hair analysis? A report about the state of investigation. |
| Q52300559 | Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. |
| Q39787530 | Basic mechanisms underlying physical dependence upon alcohol |
| Q42670953 | Behavioral alterations induced by formaldehyde-derived tetrahydroisoquinolines |
| Q70863980 | Binding of acetaldehyde to rat liver microsomes: enhancement after chronic alcohol consumption |
| Q48663724 | Biogenesis of biologically active alkaloids from amines by alcohol and acetaldehyde |
| Q69169966 | Biological Sciences: Sex Difference in Acetaldehyde Exhalation following Ethanol Administration in C57BL Mice |
| Q48481404 | Biosynthesis of Tetrahydroisoquinoline Alkaloids in Brain and other Tissues of Ethanol-Intoxicated Rats |
| Q44381437 | Blood Concentrations of Acetaldehyde and Ethanol in Chronic Alcoholics |
| Q70236567 | Catecholamines and their metabolites |
| Q66849574 | Chemical mechanism of the effect of alcohol |
| Q72550744 | Chronic ethanol administration induces tolerance to morphine and to β-endorphin responses in the rat vas deferens |
| Q67736672 | Comparison of salsolinol excretion in alcoholics and nonalcoholic controls |
| Q69786451 | Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry |
| Q77075642 | Determination of biological markers for alcohol abuse |
| Q31439866 | Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry |
| Q43919552 | Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a β-carboline infused chronically in the ventricle of the rat |
| Q35909204 | Dopamine and disease |
| Q48303488 | Dopamine levels in the striatum and the effect of alcohol and reserpine |
| Q40741098 | Dopamine release within forebrain sites perfused with tetrahydroisoquinolines or tryptoline in the rat |
| Q69576610 | Dopamine-derived tetrahydroisoquinoline alkaloids—Inhibitors of neuroamine metabolism |
| Q39812219 | Drug Interactions With Alcohol |
| Q38152218 | Effect of Chronic Alcohol Consumption on Ethanol and Acetaldehyde Metabolism |
| Q71498548 | Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat |
| Q69823605 | Effects of Aromatic Aldehydes on O-Methylation of Dopamine and Norepinephrine in in Vitro |
| Q48722187 | Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats |
| Q41529539 | Effects of ethanol and naltrexone on free-operant avoidance behavior in rats |
| Q39077472 | Effects of several catecholamine-derived tetrahydroisoquinolines on the hypogastric nerve-vas deferens preparation of the rat |
| Q37113662 | Elucidating the biological basis for the reinforcing actions of alcohol in the mesolimbic dopamine system: the role of active metabolites of alcohol |
| Q38152213 | Enzymes of Biogenic Aldehyde Metabolism |
| Q71788956 | Ethanol Preference in the Rat as a Function of Photoperiod |
| Q52284527 | Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects. |
| Q41558334 | Ethanol dependence and the pituitary-adrenal axis in mice I. Genotypic differences in hormone levels |
| Q40308451 | Ethanol effects on dopaminergic function: modulation by the endogenous opioid system. |
| Q70348793 | Ethanol metabolism and striatal dopamine turnover |
| Q48296341 | Ethanol suppression of naloxone-induced withdrawal in morphine-dependent rats |
| Q72904127 | Ethanol-induced changes of dopaminergic function in three strains of mice characterized by a different population of opiate receptors |
| Q70807677 | Evidence against a biphasic effect of acetaldehyde on voluntary ethanol consumption in rats |
| Q40082520 | Fatty liver and sudden death. A review |
| Q28821669 | Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial |
| Q48111549 | Fluorescence histochemical observations on the distribution of exogenous dihydroisoquinoline in the rat brain |
| Q44111334 | Formation of novel toxic compounds from oxidative interaction between salsolinol and cysteine |
| Q48713503 | Gerald Cohen 1930-2001. |
| Q39151846 | Hepatotoxicity of the condensation product of adrenaline with acetaldehyde |
| Q29026218 | High Blood Acetaldehyde Levels after Ethanol Administration |
| Q33852070 | Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function |
| Q93648923 | Identification and quantification of 1-carboxysalsolinol and salsolinol in biological samples by gas chromatography--mass spectrometry |
| Q48317154 | In vivo studies of catechol-o-methyl transferase activity following intoxication with ethanol, L-dopa and dopamine-derived alkaloids |
| Q48629923 | Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology |
| Q40075440 | Influence of tetrahydropapaveroline on adipose tissue metabolism in comparison with that of noradrenaline, theophylline and papaverine |
| Q48819161 | Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine |
| Q40896236 | Inhibition of High Affinity Calcium Binding by Salsolinol |
| Q41175056 | Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain |
| Q70922737 | Inhibitory effect of naloxone on the ethanol-induced antinociception in mice |
| Q41141087 | Interaction of Salsolinol and Tetrahydropapaveroline with Catecholamines |
| Q42246636 | Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors |
| Q68264374 | Interactions of salsolinol with oxidative enzymes |
| Q59807426 | Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors |
| Q43949571 | Iron enhancement of oxidative DNA damage and neuronal cell death induced by salsolinol |
| Q52264046 | Isoquinoline alkaloids as possible regulators of alcohol addiction. |
| Q28319849 | Isoquinoline alkaloids. Inhibitory actions on cation-dependent ATP-phosphohydrolases |
| Q41634669 | Isoquinoline neurotoxins in the brain and Parkinson's disease |
| Q34501515 | Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms |
| Q93701707 | L-dopa and pyridoxal 5'-phosphate: tetrahydroisoquinoline formation |
| Q34615882 | Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors. |
| Q34018453 | Metabolic Correlates of Ethanol, Acetaldehyde, Acetate and Methanol in Humans and Animals |
| Q69397064 | Metabolic effects of acetaldehyde on rat adipose tissue in vitro |
| Q48942438 | Modulation of dopamine turnover in rat retina by opiates: Effects of different pharmacological treatments |
| Q52100629 | Motion Sickness Susceptibility: Population Profiles in a General Psychiatric Population and in Heroin Addicts and Alcoholics |
| Q33659011 | Mystic Acetaldehyde: The Never-Ending Story on Alcoholism |
| Q48320655 | Naloxone-induced inhibition of ethanol dependence in mice |
| Q91666947 | Naltrexone and the Treatment of Alcohol Dependence |
| Q48388920 | Neuroamine-derived alkaloids: Substrate-preferred inhibitors of rat brain monoamine oxidase in vitro |
| Q73466546 | Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain |
| Q42730173 | Neurotoxic effects of acute and subacute formaldehyde exposures in mice |
| Q41812380 | Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopa-treated parkinsonian patients |
| Q66998234 | Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileum |
| Q34438002 | Opioid antagonists in the treatment of alcohol dependence |
| Q36918867 | Oxidation of ethanol in the brain and its consequences |
| Q71760048 | Oxidation of vanillin by cream xanthine oxidase and its inhibition by allopurinol |
| Q43628718 | Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid |
| Q68359377 | Oxidative decarboxylation of salsolinol-1-carboxylic acid to 1,2-dehydrosalsolinol: Evidence for exclusive catalysis by particulate factors in rat kidney |
| Q40117107 | Peyote, a Potential Ethnopharmacologic Agent for Alcoholism and Other Drug Dependencies: Possible Biochemical Rationale |
| Q68855008 | Phenolic cyclization of epinephrine, metaproterenol, metaraminol, phenylephrine, and terbutaline with formaldehyde |
| Q43500867 | Physical dependence following prolonged ethanol or t-butanol administration to rats |
| Q48847165 | Possible New Metabolites mediating Actions of L-Dopa |
| Q67013417 | Preference for alcohol evoked by tetrahydropapaveroline (THP) chronically infused in the cerebral ventricle of the rat |
| Q28339553 | Preparation and pharmacological activity of the condensation product of adrenaline with acetaldehyde |
| Q38558291 | Presence of tetrahydro-beta-carboline-3-carboxylic acids in foods by gas chromatography-mass spectrometry as their N-methoxycarbonyl methyl ester derivatives. |
| Q39574578 | Prevention of effects of alcohol intoxication by naloxone |
| Q41219140 | Primary and secondary prevention of alcoholism: Emerging trends and research strategy |
| Q94380925 | Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS) |
| Q34444093 | Protective action of ascorbic acid and sulfur compounds against acetaldehyde toxicity: Implications in alcoholism and smoking |
| Q34181158 | Putative Role of Isoquinoline Alkaloids in Alcoholism: A Link to Opiates |
| Q48717211 | Putative oxidative metabolites of 1-methyl-6-hydroxy-1,2,3,4-tetrahydro-beta-carboline of potential relevance to the addictive and neurodegenerative consequences of ethanol abuse |
| Q59264474 | Quantitative determination of endogenous tetrahydroisoquinoline salsolinol in peripheral blood mononuclear cells by gas chromatography-mass spectrometry |
| Q55023810 | Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release. |
| Q41060435 | Salsolinol differentially affects mice selected for sensitivity to alcohol |
| Q48895354 | Salsolinol, an alkaloid derivative of dopamine formed in vitro during alcohol metabolism |
| Q35159859 | Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system |
| Q48004001 | Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments |
| Q70637605 | Single-Breath Retention of Acetaldehyde in Man |
| Q39955083 | Speculations on the biochemical pharmacology of ethanol |
| Q66920832 | Stereoselective enzymatic O-methylation of tetrahydropapaveroline and tetrahydroxyberbine alkaloids |
| Q41130237 | Tests of opioid deficiency hypotheses of alcoholism |
| Q48663733 | Tetrahydroisoquinoline alkaloids from condensation of alcohol metabolites with norepinephrine: preparative synthesis and potential analysis in nervous tissue by gas chromatography |
| Q70648684 | Tetrahydroisoquinoline alkaloids in the adrenal medulla after perfusion with “blood concentrations” of [14C]acetaldehyde |
| Q70402412 | Tetrahydroisoquinolines and the catecholamine-binding granules of the adrenal medulla |
| Q44017457 | Tetrahydropapaveroline induces small granular vesicles in brain dopamine fibres |
| Q34052258 | The Lateral Hypothalamus, Catecholamines and Ethanol Self-Administration in Rats |
| Q39724814 | The Synaptic Properties of Some Tetrahydroisoquinoline Alkaloids |
| Q93701705 | The doctor and the adolescent |
| Q40271929 | The effect of acetaldehyde on gluconeogenesis from xylitol, sorbitol, and fructose by isolated rat liver cells |
| Q48771725 | The effect of alcoholism on salsolinol and biogenic amines in human brain |
| Q51866177 | The effect of neuroleptics, tranquillizers, narcotics, antidepressants and anticonvulsive drugs on the alterations of mouse behaviour caused by acetaldehyde |
| Q40034921 | The effects of ethanol ingestion on cyclic AMP, homovanillic acid and 5-hydroxyindoleacetic acid in human cerebrospinal fluid |
| Q72502365 | The effects of tetrahydroisoquinolinecarboxylic acids on tyrosine 3-monooxygenase |
| Q34378869 | The neurobiology of alcohol consumption and alcoholism: an integrative history |
| Q40090617 | The neurotoxicity of ethanol |
| Q36227915 | The opioidergic-alcohol link : implications for treatment |
| Q40164376 | The role of endorphins in opiate addiction, opiate withdrawal, and recovery. |
| Q33784506 | The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption |
| Q40081408 | The route and significance of endogenous synthesis of alkaloids in animals |
| Q48487708 | Tissue catecholamines and potential tetrahydroisoquinoline alkaloid metabolites: A gas chromatographic assay method with electron capture detection |
| Q68032804 | Tourette's medications: effect on minor oxidative and reductive pathways of biogenic amines |
| Q34073772 | Toxic effects of ethanol: Possible role of acetaldehyde, tetrahydroisoquinolines, and tetrahydro-β-carbolines |
| Q67938899 | Urinary elimination of salsolinol enantiomers in alcoholics |
| Q26849268 | What is in that drink: the biological actions of ethanol, acetaldehyde, and salsolinol |
| Q40741083 | d-Amphetamine and ethanol: A drug-drug interaction study |
Search more.